scholarly journals In vivo biodistribution and passive accumulation of upconversion nanoparticles in colorectal cancer models via intraperitoneal injection

RSC Advances ◽  
2017 ◽  
Vol 7 (50) ◽  
pp. 31588-31596 ◽  
Author(s):  
Yilin Gao ◽  
Xingjun Zhu ◽  
Yuwen Zhang ◽  
Xiaofeng Chen ◽  
Li Wang ◽  
...  

Cit-UCNPs after IP injection exhibited significantly different biological processes from those after IV injection. The passive-tumour targeting effectiveness of cit-UCNPs via the IP route was higher than that via the IV route.


Author(s):  
O Ogunlade ◽  
SP Johnson ◽  
E Zhang ◽  
V Rajkumar ◽  
RB Pedley ◽  
...  


2020 ◽  
pp. 403-429
Author(s):  
Zhuang Liu ◽  
Weibo Cai ◽  
Lina He ◽  
Nozomi Nakayama ◽  
Kai Chen ◽  
...  




Cancers ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 227
Author(s):  
Eileen Reidy ◽  
Niamh A. Leonard ◽  
Oliver Treacy ◽  
Aideen E. Ryan

Although there have been many advances in recent years for the treatment of colorectal cancer (CRC), it still remains the third most common cause of cancer-related deaths worldwide. Many patients with late stage CRC display resistance to multiple different therapeutics. An important aspect in developing effective therapeutics for CRC patients is understanding the interactions that take place in the tumor microenvironment (TME), as it has been shown to contribute to drug resistance in vivo. Much research over the past 100 years has focused on 2D monolayer cultures or in vivo studies, however, the efficacy in translating these to the clinic is very low. More recent studies are turning towards developing an effective 3D model of CRC that is clinically relevant, that can recapitulate the TME in vitro and bridge the gap between 2D cultures and in vivo studies, with the aim of reducing the use of animal models in the future. This review summarises the advantages and limitations of different 3D CRC models. It emphasizes how different 3D models may be optimised to study cellular and extracellular interactions that take place in the TME of CRC in an effort to allow the development of more translatable effective treatment options for patients.



RSC Advances ◽  
2015 ◽  
Vol 5 (90) ◽  
pp. 73601-73611 ◽  
Author(s):  
Huifang Liu ◽  
Guang Jia ◽  
Shizhu Chen ◽  
Huanyun Ma ◽  
Yanyan Zhao ◽  
...  

To better understand the potential impact of Gd2O3:Eu3+ nanotubes on human health, we investigated their biodistribution, subacute toxicity, and hepatic injury in mice under different dosages (4.0, 40.0, and 400.0 mg kg−1).



2006 ◽  
Vol 2 (1) ◽  
pp. 47-52 ◽  
Author(s):  
Zhuang Liu ◽  
Weibo Cai ◽  
Lina He ◽  
Nozomi Nakayama ◽  
Kai Chen ◽  
...  


2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Aurélie Rondon ◽  
Nancy Ty ◽  
Jean-Baptiste Bequignat ◽  
Mercedes Quintana ◽  
Arnaud Briat ◽  
...  


Nanomedicine ◽  
2015 ◽  
Vol 10 (8) ◽  
pp. 1223-1231 ◽  
Author(s):  
James P Tiernan ◽  
Nicola Ingram ◽  
Gemma Marston ◽  
Sarah L Perry ◽  
Jo V Rushworth ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document